• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Prostasin as a diagnositc and therapeutic target for salt-sensitive hypertension

Research Project

Project/Area Number 17590834
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKumamoto University

Principal Investigator

KITAMURA Kenichiro  Kumamoto University, Faculty of Medical and Pharmaceutical Sciences, Research Associate, 大学院医学薬学研究部, 助手 (10304990)

Co-Investigator(Kenkyū-buntansha) TOMITA Kimio  Kumamoto University, Faculty of Medical and Pharmaceutical Sciences, Professor, 大学院医学薬学研究部, 教授 (40114772)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2005: ¥1,800,000 (Direct Cost: ¥1,800,000)
Keywordssodium channels / serine protease / prostasin / hypertension
Research Abstract

Generation of transgenic animal models for prostasin
We developec an adenoviral vector carrying human prostasin cDNA and injected into Wister rats. Rats expressing human prostasin gene showed high blood pressure and hyper aldosteronism. These phenotypes were abolished when the adrenal glands were removed prior to the virus injection, suggesting :hat adrenal gland is responsible for the prostasin mediated hyperaldosteronism.
Application for the diagnosis of salt-sensitive hypertension in humans
We developed prostasin specific RIA system to elucidate the causative role of prostasin in the hypertension in humans. We measured urinary prostasin levels in 121 hypertensive patients and 26 healthy volunteers. We found that urinary prostasin levels had strong positive correlation with urinary aldosterone levels as well as with urinary Na/K ratio which is a marker for the activity of the epithelial sodium channels in the kidney. We also showed a positive correlation between urinary prostasin and plasma aldosterone levels.
Taken together, these findings suggest that urinary prostasin levels might be a good marker for the ENaC activities in the renal tubules. Previously, we demonstrated that aldosterone induces urinary prostasin expression in primary aldosteronism patients. Our current research data indicate the important relationship between aldosterone and prostasin in general hypertensive population.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (16 results)

All 2007 2006 2005

All Journal Article (16 results)

  • [Journal Article] An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure.2007

    • Author(s)
      Shimoishi K., et al.
    • Journal Title

      Pharm.Res. (in press)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Effect of Olmesartan on Oxidative Stress in Hemodialysis Patients2007

    • Author(s)
      Kadowaki D., et al.
    • Journal Title

      Hypertens.Res. (in press)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-β1 and aldosterone2006

    • Author(s)
      Wakida N., et al.
    • Journal Title

      Kidney Int. 70

      Pages: 1432-1438

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Successful treatment in a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium2006

    • Author(s)
      Shiraishi N., et al.
    • Journal Title

      Am. J. Kidney Dis. 48

      Pages: 151-154

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-β3 1 and, aldosterone2006

    • Author(s)
      Wakida N., et al.
    • Journal Title

      Kidney Int. 70

      Pages: 1432-1438

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Successful treatment in a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium2006

    • Author(s)
      Shiraishi N., et al.
    • Journal Title

      Am.J.Kidney Dis. 48

      Pages: 151-154

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Mutations in hURAT1 gene in pre-secretory reabsorption defect type of familial renal hypouricemia2005

    • Author(s)
      Wakida, N. et al.
    • Journal Title

      J. Clin. Endocr. Metab. 90

      Pages: 2169-2174

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Fibrocystin Interacts with CAML, A Protein Involved in Ca2+ Signaling2005

    • Author(s)
      Nagano, J. et al.
    • Journal Title

      Biochem. Biophys. Res. Commun. 338

      Pages: 880-889

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] The structure and function of oxidized albumin in hemodialysis patients2005

    • Author(s)
      Mera, K. et al.
    • Journal Title

      Biochem. Biophys. Res. Commun. 334

      Pages: 1322-1328

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Effect of telmisartan on ABPM, plasma BNP, and oxidative status of serum albumin in hemodialysis patients2005

    • Author(s)
      Shimada, H. et al.
    • Journal Title

      Hypertens. Res. 28

      Pages: 987-994

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Fibrocystin Interacts with CAML, A Protein Involved in Ca2+ Signaling2005

    • Author(s)
      Nagano, J.et al.
    • Journal Title

      Biochem.Biophys.Res.Commun. 338

      Pages: 880-889

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Effect of telmisartan on ABPM, plasma BNP, and oxidative status of serum albumin in hemodialysis patients2005

    • Author(s)
      IShimada, H.et al.
    • Journal Title

      Hypertens.Res. 28

      Pages: 987-994

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Oxidation and Carboxyl methyl lysine(CML)-modification of albumin ; Possibie involvement in the progression of oxidative stress in hemodialysis patients2005

    • Author(s)
      Mera, K.et al.
    • Journal Title

      Hypertens.Res. 28

      Pages: 973-980

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Familial pseudohyperkalemia : a rare syndrome, but diverse genetic heterogeneity2005

    • Author(s)
      Kitamura, K.et al.
    • Journal Title

      Intern Med. 44

      Pages: 781-782

    • NAID

      130000076334

    • Related Report
      2005 Annual Research Report
  • [Journal Article] The structure and function of oxidized album in hemodialysis patients ; its role in elevated oxidative stress via neutrophil burst2005

    • Author(s)
      Mera, K.et al.
    • Journal Title

      Biochem.Biophys.Res.Common. 334

      Pages: 1322-1328

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Mutations in hURAT1 gene in pre-secretory reabsorption defect type of familial renal hypouricemia2005

    • Author(s)
      Wakida, N. et al.
    • Journal Title

      J.Clin.Endocr.Metab. 90

      Pages: 2169-2174

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi